Widad: Clinical trial for Covid-19 vaccine passes phase one


Widad is collaborating with Rinani Dynamic Sdn Bhd to distribute the oral vaccine in Malaysia. It is being developed by US-based biotechnology company Vaxart.

KUALA LUMPUR: Widad Group Bhd’s foray into distributing an oral-based (tablet) Covid-19 vaccine developed by Vaxart, Inc moved a step forward after the phase one of the clinical trial achieved positive response.

Widad is collaborating with Rinani Dynamic Sdn Bhd to distribute the oral vaccine in Malaysia. It is being developed by US-based biotechnology company Vaxart.

Save 30% for ads-free and full access now!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Others Also Read


Want to listen to full audio?

Unlock unlimited access to enjoy personalise features on the TheStar.com.my

Already a member? Log In